2019
DOI: 10.3390/v11100893
|View full text |Cite
|
Sign up to set email alerts
|

Gray (Oreochromis niloticus x O. aureus) and Red (Oreochromis spp.) Tilapia Show Equal Susceptibility and Proinflammatory Cytokine Responses to Experimental Tilapia Lake Virus Infection

Abstract: Tilapia is the second most farmed fish species after carp in the world. However, the production has come under threat due to emerging diseases such as tilapia lake virus (TiLV) that causes massive mortalities with high economic losses. It is largely unknown whether different tilapia strains are equally susceptible to TiLV infection. In the present study we compared the susceptibility of gray (Oreochromis niloticus x O. aureus) and red tilapia (Oreochromis spp.) to experimental TiLV infection. Virus was injecte… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
16
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 25 publications
(17 citation statements)
references
References 26 publications
(41 reference statements)
1
16
0
Order By: Relevance
“…Tilapia tilapinevirus, aka tilapia lake virus (TiLV), was first described in farmed and wild tilapia in Israel [4] and later reported in sixteen additional countries [2,48,49]. Although the potency of TiLV has been demonstrated in various species of tilapia including Nile tilapia (Oreochromis niloticus), blue tilapia (O. aureus), and its hybrid species [4,5,15,42,50,51], there have been no reports of TiLV infection in Mozambique tilapia, which is genetically close to the Nile tilapia, a susceptible host to TiLV infection. This study showed that Mozambique tilapia (O. mossambicus) is also susceptible to TiLV infection.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…Tilapia tilapinevirus, aka tilapia lake virus (TiLV), was first described in farmed and wild tilapia in Israel [4] and later reported in sixteen additional countries [2,48,49]. Although the potency of TiLV has been demonstrated in various species of tilapia including Nile tilapia (Oreochromis niloticus), blue tilapia (O. aureus), and its hybrid species [4,5,15,42,50,51], there have been no reports of TiLV infection in Mozambique tilapia, which is genetically close to the Nile tilapia, a susceptible host to TiLV infection. This study showed that Mozambique tilapia (O. mossambicus) is also susceptible to TiLV infection.…”
Section: Discussionmentioning
confidence: 99%
“…and Nile tilapia (O. niloticus), with cumulative mortality in these species ranging from 63-86% [17,42]. Mugimba et al (2019) [15] reported 80-100% mortality in gray tilapia (O. niloticus × O. aureus) and red tilapia (Oreochromis spp.) after experimental challenge by TiLV.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Nevertheless, more research regarding the factors associated with high mortalities in coinfection including dampening of the fish immune response during TiLV infection needs to be confirmed. In a recent study, high expression of pro‐inflammatory cytokines including IL‐1β and TNF‐α was discovered in the brain and kidneys, while these genes were not as highly expressed in the liver of TiLV‐challenged fish (Mugimba et al., 2019). Another study demonstrated that injecting TiLV in zebrafish induced high type I IFN response (Rakus et al., 2020) Moreover, different genes including erythropoietin isoform X2, double‐stranded RNA‐specific adenosine deaminase isoform X1, bone morphogenetic protein 4 and tapasin‐related proteins as well as differentially expressed mRNAs are involved in immune responses during TiLV infection (Wang, Wang, et al, 2020).…”
Section: Tilv Pathogenesismentioning
confidence: 99%
“…Verification of virus species used for the HA assay was carried out using total RNA extracted from cell culture supernatants for the TiLV and ISAV, whereas the allantois fluid was used for the extraction of total RNA for influenza virus PR8 using a modification of the Trizol (GIBCO, Life Technologies, Gaithersburg, MD, USA) and RNAeasy Mini kits (Qiagen, Hilden, Germany), as previously described [27]. cDNA synthesis was carried out in 20 µL reaction volumes using the Qiagen quantiTect ® reverse transcription kit that involved an integrated step for the removal of contaminated genomic DNA (Qiagen), as previously described in our studies [28]. TiLV, PR8, and ISAV nucleic acids were amplified using primers specific to each virus, as shown in Table 1, targeting segment 3 for TiLV, segment 7 for PR8, and segment 8 for ISAV.…”
Section: Verification Of Virus Species Used For the Hemagglutination mentioning
confidence: 99%